Patents by Inventor Ariel C. Hollnshead

Ariel C. Hollnshead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    Patent number: 7763720
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: July 27, 2010
    Assignee: Neogenix Oncology, Inc.
    Inventors: Myron Arlen, J. Andrew Bristol, Ariel C. Hollnshead, Kwong Y. Tsang